The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis

K Evangelou1, J Bartkova, A Kotsinas

  • 1Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece.

Insights

The alternative reading frame (ARF) tumor suppressor is activated later than the DNA damage response (DDR) during cancer progression. ARF acts as a delayed barrier against tumor development, requiring higher oncogenic stress signals than DDR.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Oncogenic stimuli activate the DNA damage response (DDR) and alternative reading frame (ARF) tumor suppressor.
  • Both pathways can activate the p53 pathway, a critical barrier to tumor progression.
  • The timing and signal thresholds for ARF induction versus DDR activation during tumorigenesis are not well understood.

Purpose of the Study:

  • To investigate the temporal relationship and signal thresholds for ARF induction and DDR activation during tumorigenesis.
  • To compare these events in various preclinical and clinical cancer models.

Main Methods:

  • Analysis of mouse models of premalignant and malignant lesions in the urinary bladder, colon, pancreas, and skin.
  • Examination of human clinical samples from early and progressive lesions of the urinary bladder, head and neck, skin, and pancreas.
  • Mechanistic studies using epithelial and fibroblast cell models exposed to oncogenes.

Main Results:

  • ARF expression consistently occurred at later stages of tumor progression than DDR activation or p16(INK4A) induction across all models.
  • Similar temporal patterns were observed in human cancer lesions.
  • Mechanistic studies revealed that ARF upregulation requires a higher oncogenic stress threshold (at least two oncogenic 'hits') compared to DDR activation.

Conclusions:

  • ARF induction is a delayed event in tumorigenesis relative to DDR activation.
  • ARF functions as a complementary, delayed barrier to tumor development, responding to more significant oncogenic stress.
  • This suggests a stepwise model of tumor suppression involving distinct responses to escalating oncogenic stimuli.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...